Condition: Traumatic Brain Injury · Sponsor: London School of Hygiene and Tropical Medicine
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
This description comes directly from the study's public registry record.
Haleema Shakur-Still · +4407714139500 · Haleema.Shakur@lshtm.ac.uk
Always discuss trial participation with your own doctor first.
| The Royal London Hospital | London, London, United Kingdom | Recruiting |
| St George's Hospital | London, London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04521881